X

Xenon Pharmaceuticals
D

XENE

38.310
USD
0.21
(0.55%)
مغلق
حجم التداول
40,961
الربح لكل سهم
-4
العائد الربحي
-
P/E
-13
حجم السوق
2,934,300,931
أصول ذات صلة
A
AKRO
-0.370
(-0.82%)
44.910 USD
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
A
ARCT
0.350
(2.80%)
12.850 USD
BIIB
BIIB
2.500
(2.07%)
123.460 USD
F
FULC
1.24000
(28.44%)
5.60000 USD
GOOGL
GOOGL
1.610
(0.99%)
164.010 USD
المزيد
الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.